Home LiteratureArticle Details
PMID: 2567402 Published · ppublish English Letter

Anti-CD3 antibody for autoimmune disease, a cautionary note.

Lancet (London, England) ·Vol. 1 ·No. 8651 ·1989-06-17 ·Pages 1390

Hirsch R, Gress RE, Bluestone JA

Abstract

暂无摘要

MeSH Terms
Antibodies, Monoclonal/adverse effects Autoimmune Diseases/drug therapy Humans Immunosuppression Therapy Lymphocyte Activation/drug effects Muromonab-CD3 Product Surveillance, Postmarketing
Chemicals
Antibodies, Monoclonal Muromonab-CD3
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Hirsch R
Gress R E
Bluestone J A
Article Info
Journal
Lancet (London, England)
Abbr.
Lancet
ISSN
0140-6736
DOI
10.1016/s0140-6736(89)92835-3
Published
1989-06-17
Pages
1390
Language
English
Region
England
NLM ID
2985213R
Subset
IM
Corrections
CommentIn
PMID: 2567934
External Links
PubMed source DOI: 10.1016/s0140-6736(89)92835-3 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2